KR20110121487A - Medical plant extract having anti-oxident and anti-inflammatry activity and method of production thereof - Google Patents

Medical plant extract having anti-oxident and anti-inflammatry activity and method of production thereof Download PDF

Info

Publication number
KR20110121487A
KR20110121487A KR1020100041094A KR20100041094A KR20110121487A KR 20110121487 A KR20110121487 A KR 20110121487A KR 1020100041094 A KR1020100041094 A KR 1020100041094A KR 20100041094 A KR20100041094 A KR 20100041094A KR 20110121487 A KR20110121487 A KR 20110121487A
Authority
KR
South Korea
Prior art keywords
extract
activity
herbal
eugenol
active ingredient
Prior art date
Application number
KR1020100041094A
Other languages
Korean (ko)
Inventor
최상원
김은옥
임현희
서미자
Original Assignee
대구가톨릭대학교산학협력단
서미자
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대구가톨릭대학교산학협력단, 서미자 filed Critical 대구가톨릭대학교산학협력단
Priority to KR1020100041094A priority Critical patent/KR20110121487A/en
Publication of KR20110121487A publication Critical patent/KR20110121487A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/14Cupressaceae (Cypress family), e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/26Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/264Aristolochia (Dutchman's pipe)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: An oriental medicine material extract containing eugenol derivatives and a method for preparing the same are provided to ensure antioxidation, anti-aging, and anti-inflammation. CONSTITUTION: A method for preparing steam distillation extract of oriental medicine materials comprises: a step of drying herb medicines and adding distilled water; a step of adding ether and isolating with a steam distillation device; and a step of decompressing. A functional composition for antioxidation or antiaging contains the extract as an active ingredient. A functional composition for anti-inflammation contains the extract as an active ingredient. The extract contains eugenol derivatives as an active ingredient. The eugenol derivative is methyleugenol or acetyleugenol.

Description

Eugenol 유도체를 함유하는 항산화 및 항염증 활성 한약재 추출물 및 그 제조방법{Medical plant extract having anti-oxident and anti-inflammatry activity and method of production thereof}Medicinal plant extract having anti-oxident and anti-inflammatry activity and method of production

본 발명은 항산화, 항노화 및 항염증 활성을 동시에 가지는 한약재의 추출물에 관한 것으로 eugenol과 methyleugenol, acetyleugenol 등 생리활성이 있는 eugenol 유사물질이 함유된 한약재 추출물에 관한 것이다.
The present invention relates to extracts of herbal medicines having anti-oxidant, anti-aging and anti-inflammatory activities at the same time. The present invention relates to extracts of herbal medicines containing eugenol-like substances with physiological activities such as eugenol and methyleugenol and acetyleugenol.

자유라디칼 혹은 활성산소에 의한 생체내에서의 산화는 노화와 질병의 원인이 된다는 사실은 많이 규명되었다. 자유라디칼 혹은 활성산소는 인체내에서 지질과 당의 산화, 단백질의 변성, DNA의 전달을 유발하여 생체 세포막과 유전자 손상을 초래하여 노화와 질병 기타 암의 원인이 되고 있다. 따라서, 자유라디칼 혹은 활성산소의 소거능을 가지는 물질의 탐색연구가 활발히 수행되고 있다(John M. et. al., 1994). 국내특허 제10-439012호는 헛개나무로부터 항산화 및 항노화 활성물질의 추출방법으로 헛개나무 잎을 70~99℃에서 15분간 열수추출하고 원색분리한 다음 동결건조하여 분말을 제공한 다음 메탄올로 녹이고 여과한 여액을 38℃에서 감압농축한 메탄올 가용추출물로부터 4-히드록시-3-메톡시 벤조산 등을 분리 동정하는 기술을 개시하고 있다.It has been found that oxidation in vivo by free radicals or free radicals causes aging and disease. Free radicals or free radicals cause lipid and sugar oxidation, protein denaturation, and DNA transfer in the human body, resulting in biological cell membranes and gene damage, causing aging, disease, and other cancers. Therefore, the search for a substance having a free radical or active oxygen scavenging ability has been actively conducted (John M. et. Al., 1994). Korean Patent No. 10-439012 is a method of extracting antioxidant and anti-aging active substances from the bark tree, and the leaves of the bark tree are extracted with hot water at 70-99 ° C. for 15 minutes, separated by primary color, lyophilized to provide powder, and then dissolved with methanol. Disclosed is a technique for separating and identifying 4-hydroxy-3-methoxy benzoic acid and the like from a methanol soluble extract obtained by concentrating the filtered filtrate under reduced pressure at 38 ° C.

또, 국내특허 제10-499455호에서 홍국 모나스쿠스속 곰팡이로부터 3-히드록시-3-메틸글루타릴조효소A(HMG-CoA) 환원제 길항작용을 하는 항산화물질 Monacollin K 추출 방법이 개시되어 있다.In addition, Korean Patent No. 10-499455 discloses a method for extracting the antioxidant Monacollin K which antagonizes 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reducing agent from the fungus of the genus Monascus.

또한, 인체 세포나 조직, 기관의 노화를 촉진시키는 생체화합물인 superoxide, H2O2, OH와 같은 활성산소 종들의 대사산물로 생성된 free radical 들이 생체내에서, 단백질의 변성, 나아가 생체세포막 및 DNA에 산화적 손상을 주는데 이들의 산화기능을 억제하기 위한 항산화제 내지 항노화제로서는 vitamin C, vitamin E, N-acetyl-L-Cysteine, S-al1rlyl-L-Cysteine, oltipraz 와 같은 천연 화합물과 PBN(α-phenyl-N-t-butyl nitrone) 등이 보고되고 있는데 국내특허 제10-535266호에는 인삼을 마쇄하여 에탄올로 추출한 다음 동결건조한 추출물 한약재 지각, 차전자, 인동, 정향, 천궁 추출액에 비하여 뛰어난 항산화 및 항노화 효과가 있음을 개시하고 있다.
In addition, free radicals generated from metabolites of active oxygen species such as superoxide, H 2 O 2 , and OH, which are biological compounds that promote the aging of human cells, tissues, and organs, can be denatured in vivo, furthermore, protein cell membranes and Antioxidants or anti-aging agents which inhibit oxidative function of DNA and inhibit their oxidative function include vitamin C, vitamin E, natural compounds such as N-acetyl-L-Cysteine, S-al1rlyl-L-Cysteine and oltipraz PBN (α-phenyl-Nt-butyl nitrone) has been reported.In Korean Patent No. 10-535266, ginseng is ground and extracted with ethanol, and then lyophilized extract is better than crust, tea, phosphorus, cloves and celery extract. It is disclosed that it has antioxidant and anti-aging effects.

한편, 인체의 염증은 세균 유래의 농양으로서 조직세포에 침입하여 증식된 황농균규를 백혈구가 탐식하여 그 결과로서 생기는 백혈구의 사체, 장해를 받은 조직세포의 파괴물이 조직내에 융해되어 축적된 곳의 병리적 상태를 말한다. 또, 소염작용이라함을 침입균의 증식을 항생제 또는 항균제 등에 의하여 억제한다든지 혹은 농양중에 축적된 이물질을 탐식하는 macrophage를 활성화하여 그것들을 소화, 배설하는 기능을 촉진하는 것을 말한다.
Inflammation of the human body, on the other hand, is a bacterium-induced abscess, where white blood cells invade and proliferate Pseudomonas aeruginosa, resulting in the death of white blood cells and the destruction of damaged tissue cells. Refers to a pathological condition. In addition, the anti-inflammatory action refers to inhibiting the growth of invading bacteria by antibiotics or antibacterial agents, or to promoting the function of digesting and excreting them by activating the macrophage that phages foreign substances accumulated in the abscess.

일반적으로 염증 반응은 생체의 세포나 조직에 기질적 변화를 가져오는 침습에 노출될 때 그 손상부위를 수복 재생하려고 하는 생체의 방어 반응과정이다. 따라서, 이러한 방어기작에는 국소적인 혈관, 체액의 각종 조직세포 및 면역세포 등이 포함된다.In general, the inflammatory response is a biological defense process that attempts to repair and repair the damaged area when exposed to an invasion that causes organic changes in cells or tissues. Therefore, these defense mechanisms include local blood vessels, various tissue cells of body fluids and immune cells.

항염증 작용물질은 이러한 방어반응과정에서 손상된 조직의 세포나 염증에 관여하는 세포 또는 백혈구의 세포막으로 부터 자극되어 활성화된 프로스타글란딘류의 생합성을 억제하는 약물이 주가 되었다(Moyazawa et, al., 1985). 그러나 이와 같은 약물들은 주로 금성염증에 치료효과가 있으나 류마티스관절염 같은 만성염증에는 완화치료 작용만 있을 뿐, 면역학적 치료효과는 기대할 수 없었다. 따라서, 최근에는 아라키돈산(arachidonic acid)이 리폭시게네이즈(lipoxy genase)에 의해 생성되는 물질(HETE), 류코트리엔 B4, 류코트리엔 C4 등이 활발히 연구되고 있다. 국내특허 10-447948호에는 염증반응인자로서 본 체게활성억제, 산화질소(NO)생성억제효과가 있어 항염증 활성 및 항동맥경화활성을 추출물과 헥산분획물 및 클로르포름 분획물, 부탄분획물이 개시되어 있다. 또 국내특허 제10-441565호에는 건조된 메밀 또는 메밀껍질을 에탄올 추출물 TPA에 의해 유발되는 항염증효능이 개시되어 있다.Anti-inflammatory agents are mainly drugs that inhibit the biosynthesis of activated prostaglandins by stimulating from the cells of damaged tissues, the cells involved in inflammation, or the membranes of white blood cells (Moyazawa et, al., 1985). . However, these drugs were mainly effective in treating venus inflammatory disease, but in chronic inflammation such as rheumatoid arthritis, only palliative treatment effect was not expected. Therefore, in recent years, arachidonic acid is produced by lipoxy genase (HETE), leukotriene B 4, leukotriene C 4 and the like are actively studied. Korean Patent No. 10-447948 discloses extracts, hexane fractions, chlorform fractions and butane fractions as anti-inflammatory activity and anti-arteriosclerosis activity as an inhibitory effect on body body and nitric oxide (NO). . In addition, Korean Patent No. 10-441565 discloses the anti-inflammatory effect of the dried buckwheat or buckwheat husk caused by the ethanol extract TPA.

그러나, 지금까지 eugenol 유도체를 가진 항산화, 항노화 및 항염증 등 생리활성을 동시에 가지는 한약재 추출물은 연구된 바 없다.
However, until now, no herbal extracts with eugenol derivatives having physiological activities such as antioxidant, anti-aging and anti-inflammatory have been studied.

따라서, 본 발명은 Eugenol 유도체를 가지며 항산화, 항노화 및 항염증 활성을 동시에 가지는 한약재 추출물을 제공하는 데 그 목적이 있다.
Accordingly, an object of the present invention is to provide an herbal extract having Eugenol derivatives and simultaneously having antioxidant, anti-aging and anti-inflammatory activity.

본 발명의 상기 목적은 Eugenol 유도체를 함유하는 한약재를 선택하고 이를 자연 발효 숙성 시킨다음 증류수를 가한 후 에테르를 넣어 추출한 다음 감압농축하여 수증기 증류액을 얻어 이를 냉각 저장하고 항산화, 항노화 및 항염증 효능을 평가함으로써 달성하였다.
The above object of the present invention is to select a herbal medicine containing Eugenol derivatives, and then fermented to natural fermentation, and then added with distilled water, extracted with ether, concentrated under reduced pressure to obtain a steam distillate, which is cooled and stored for antioxidant, anti-aging and anti-inflammatory effects. Was achieved by evaluating

이하, 본 발명의 구체적인 내용을 실시예를 들어 설명한다.
Hereinafter, specific examples of the present invention will be described with reference to Examples.

본 발명 한약재의 수증기 증류액은 eugenol 유도체를 함유하여 항산화, 항노화 및 항염증 등 생리활성이 뛰어난 효과가 있다.
The steam distillate of the herbal medicine of the present invention contains eugenol derivatives and has excellent physiological activities such as antioxidant, anti-aging and anti-inflammatory.

도1은 본 발명의 한약재를 이용한 수증기 증류액을 제조하는 과정을 도시한 그림이다.
도2는 본 발명 한약재를 이용한 생리활성물질을 제조하기 위한 수증기 증류액의 증류장치를 보인 사진도이다.
도3은 본 발명 생약재 원료별 수증기 증류액의 5-LO 및 COX-2 저해효과를 보인 그래프이다.
도4는 본 발명을 구성하는 정향의 향기성분의 GC-MS Spectra를 보인 것이다.
도5는 비교예 8종의 한방 증류액(A)과 본 발명 10종의 생약재 수증기 증류액(B)의 GC-MS Spectra를 보인 것이다.
도6은 비교예 8종의 한방증류액(A)과 본 발명 10종의 생약재 수증기 증류액(B)의 GS-MS Spectra를 보인 것이다.
도7은 비교예 8종의 한방증류액과 본 발명 10종의 생약재 수증기 증류액의 항산화 활성을 보인 그래프이다.
1 is a diagram illustrating a process of preparing a steam distillate using the herbal medicine of the present invention.
Figure 2 is a photograph showing a distillation apparatus of the steam distillate for producing a bioactive material using the herbal medicine of the present invention.
Figure 3 is a graph showing the 5-LO and COX-2 inhibitory effect of the steam distillate for each herbal medicine raw material of the present invention.
Figure 4 shows the GC-MS Spectra of the flavor component of the clove constituting the present invention.
Figure 5 shows the GC-MS Spectra of eight herbal distillates (A) of Comparative Example and 10 herbal herb vapor distillates (B) of the present invention.
Figure 6 shows the GS-MS Spectra of eight herbal distillates (A) of Comparative Example and 10 kinds of herbal distillates (B) of the present invention.
7 is a graph showing the antioxidant activity of eight herbal distillates of Comparative Examples and the herbal distillates of ten herbs of the present invention.

본 발명 Eugenal 유도체를 함유한 수증기 증류액은 도1과 같이 제조하였다.
The steam distillate containing Eugenal derivative of the present invention was prepared as shown in FIG.

즉, 본 발명 수증기 증류액은 <비교예>와 달리 노간주, 목향, 천궁, 당귀, 정향, 고본, 박하, 애엽 외에도 세신, 상백피를 더 추가하여 10가지를 선택하고 하기 실시예와 같이 제조하였다.
In other words, the steam distillate of the present invention, unlike <Comparative Example> was added in addition to sensinju, Mokhyang, Cheongung, Angelica, Clove, Gobon, Peppermint, Apricot, and further added to the Shinsin, Sangbaekpi and prepared as in the following examples.

한약재는 (주)하늘호수의 재료, 제품을 사용하였다.
Herbal medicine used materials and products of Sky Lake Co., Ltd.

<실시예><Examples>

(주)하늘호수로 부터 구입한 노간주, 목향, 천궁, 당귀, 정향, 고본, 박하, 애엽, 세신, 상백피를 도1에 도시한 바와 같이 30~60일 건조하여 자연 발효숙성한 것을 도2의 가열탱크 및 증류시설을 통하여 증류수를 넣어 가열한 다음 증류시켰다.Co., Ltd. purchased from Sky Lake Co., Ltd., Mokyang, Cheongung, Dongguk, Clove, Gobon, Peppermint, Love Leaf, Sessin, Sangbaekpi as shown in Fig. Distilled water was added through a heating tank and a distillation unit, followed by heating.

건조후 자연 발효 숙성한 한약재 생약 10종 50g에 증류수 500mL를 가하고 또 다른 수기에 에테르 250mL를 넣어 수중기 증류장치(도2) 이용하여 4시간 추출한 후 얻어진 에테르를 감압농축 및 질소로 농축하여 수증기 증류액을 얻어 냉가, 저장하고 항산화, 항노화 및 항염증 효능 평가에 사용하였다.
After drying, fermented 500 g of 10 kinds of Chinese herbal medicines aged naturally fermented, 500 ml of distilled water was added, and 250 mL of ether was added to another water extract using an underwater distillation apparatus (Figure 2) for 4 hours, and the ether obtained was concentrated under reduced pressure and concentrated with nitrogen. The solution was obtained, cooled, stored and used for the evaluation of antioxidant, anti-aging and anti-inflammatory efficacy.

<비교예>Comparative Example

상기 실시예에서 10종의 생약재에서 세신과 상백피를 제외한 8종의 기존의 한약재를 사용하여 동일한 방법으로 한방 증류액을 얻었다.
In the above examples, herbal distillates were obtained by the same method using 10 conventional herbal medicines except for ten medicinal herb and sesame and baekbaekpi.

실험 결과(표 1), 8가지 생약의 기존의 한방 증류액 수율은 정향이 건물 100 g 중 16,340.3 mg으로 가장 높았고 목향 428.0 mg, 고본 419.0 mg, 천궁 352.4 mg, 박하 227.0 mg, 당귀 196.0 mg, 노간주 105.6 mg 순으로 나타났으며, 애엽이 56.0 mg으로서 가장 낮았다.  Experimental results (Table 1), the yield of the traditional herbal distillate of the eight herbs was the highest clove was 16,340.3 mg of 100 g of dry matter, 428.0 mg, Gobon 419.0 mg, Cheongung 352.4 mg, Mint 227.0 mg, Angelica 196.0 mg, Angelica juju In order of 105.6 mg, the leaves were the lowest as 56.0 mg.

Figure pat00001

Figure pat00001

<실험예1> 생리활성 특정Experimental Example 1 Specific Biological Activity

항산화 활성Antioxidant activity

8가지 생약 중 수증기증류액의 수율이 높았던 정향 및 고본의 항산화활성은 Tagashira M. and Ohtake Y.등(1998)의 방법에 따라 0.1 mM DPPH 용액 2 mL에 증류액 0.1 mL를 가하고 vortex하여 실온에서 10분간 반응시킨 후 517 nm에서 흡광도를 측정하였다. DPPH 라디칼소거활성은 아래의 식을 이용하여 계산하였으며, 그 값은 IC50치(50%의 저해활성을 나타내는 농도)로 나타내었다. Antioxidant activity of clove and hardwood, which had a high yield of water vapor distillation among eight herbal medicines, was added to 2 mL of 0.1 mM DPPH solution according to the method of Tagashira M. and Ohtake Y. et al. (1998), and 0.1 mL of distillate was vortexed at room temperature. After reacting for 10 minutes, the absorbance at 517 nm was measured. DPPH radical scavenging activity was calculated using the following equation, and the value was expressed as IC 50 value (concentration showing 50% inhibitory activity).

DPPH 라디칼소거활성(%)=(1-시료첨가구의 흡광도/무첨가구의 흡광도)×100
DPPH radical scavenging activity (%) = (absorbance of 1-sample addition / absorption of no addition) x 100

실험 결과, 8가지 생약 중 수증기증류액의 수율이 높았던 정향 및 고본의 DPPH 라디칼소거활성은 정향(IC50=8.85 μg/mL)이 고본(IC50=1.25 mg/mL)보다 포착활성이 컸으며, 아울러 정향은 천연항산화물질인 α-tocopherol(12.32 μg/mL)보다 더 높은 포착활성을 나타내었다(표 2).As a result, DPPH radical scavenging activity of cloves and high bones, which had high yield of water vapor distillation, was higher in cloves (IC 50 = 8.85 μg / mL) than in the originals (IC 50 = 1.25 mg / mL). In addition, the clove showed a higher capture activity than the natural antioxidant α-tocopherol (12.32 μg / mL) (Table 2).

Figure pat00002

Figure pat00002

항노화 활성Anti-aging activity

항노화 활성은 Masamoto et al., 등(2003)의 방법을 변형하여 다음과 같이 측정 하였으며, tyrosinase 조효소액은 mushroom tyrosinase(1380 u/mL)를 0.1 M sodium phosphate buffer(pH 6.8)에 용해하여 사용하였다. 효소활성의 측정은 0.1 M sodium phosphate buffer 500 μL, 증류수 450 μL, 추출물 50 μL, tyrosinase 50 μL 순으로 첨가한 후 기질인 2.5 mM L-DOPA 500 μL를 혼합하여 37℃에서 1분간 반응시키고 475 nm에서 흡광도를 측정하였다. tyrosinase 저해활성은 DPPH 라디칼 소거활성 계산 방법과 동일하며, 그 값은 IC50치(50%의 저해활성을 나타내는 농도)로 나타내었다.
Anti-aging activity was determined by modifying the method of Masamoto et al., Et al. (2003) as follows. Tyrosinase coenzyme solution was used by dissolving mushroom tyrosinase (1380 u / mL) in 0.1 M sodium phosphate buffer (pH 6.8). It was. Enzyme activity was measured in 500 μL of 0.1 M sodium phosphate buffer, 450 μL of distilled water, 50 μL of extract, and 50 μL of tyrosinase. Then, 500 μL of 2.5 mM L-DOPA was mixed and reacted at 37 ° C. for 1 minute. Absorbance was measured at. The tyrosinase inhibitory activity was the same as the DPPH radical scavenging activity calculation method, and the value was expressed as IC 50 value (concentration showing 50% inhibitory activity).

실험 결과, 8가지 생약 중 수증기증류액의 수율이 높았던 정향 및 고본의 tyrosinase 저해활성은 정향(IC50=160.4 μg/mL)이 고본(IC50=20.36 mg/mL)보다 저해활성이 컸으며, 한편 정향은 천연항산화물질인 ascorbic acid(66.62 μg/mL)보다는 낮은 저해활성을 나타내었다(표 3).Were a result, 8 kinds of crude drugs of the yield was high cloves and tyrosinase inhibitory activity of gobon the steam distillate cloves (IC 50 = 160.4 μg / mL ) The inhibitory activity is larger than gobon (IC 50 = 20.36 mg / mL ), Clove showed lower inhibitory activity than the natural antioxidant ascorbic acid (66.62 μg / mL) (Table 3).

Figure pat00003

Figure pat00003

항염증 작용(5-LO 및 COX-2 저해활성)Anti-inflammatory action (5-LO and COX-2 inhibitory activity)

세포 배양: Murine macrophage cell line RAW 264.7 세포를 Korean Cell Line Bank(KLCB)로부터 분양받아 사용하였으며, 10% fetal bovine serum(FBS)과 1% antibiotics(penicillin/ streptomycin)를 첨가한 Dulbecco's modified Eagle's medium (DMEM) 배지를 이용하여 5% CO2가 존재하는 37℃ incubator에서 2~3일에 한 번씩 계대배양을 시행하였다. 세포는 96 well plate(1 × 105 cells/well)에 주입하여 부착시키고, 시료와 lipopolysaccharide (LPS) 100 ng/mL를 첨가하여 24시간 배양시킨 후 실험에 이용하였다. Cell culture: Murine macrophage cell line RAW 264.7 cells were obtained from Korean Cell Line Bank (KLCB), and Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS) and 1% antibiotics (penicillin / streptomycin) was added. Subcultures were performed every 2 to 3 days in a 37 ° C incubator with 5% CO 2 . Cells were injected into 96 well plates (1 × 105 cells / well), adhered to the cells, and 100 ng / mL of lipopolysaccharide (LPS) was added and cultured for 24 hours.

5-LO 저해 활성 측정: 5-LO 저해 효능 측정은 lipoxygenase inhibitor screening assay kit를 이용하여 실험하였다. 샘플 10 μL에 5-LO (220 units/mL) 90 μL와 1 mM 아라키돈산 10 μL를 첨가하여 5분간 상온에서 반응시킨 후, 색원체(chromogen) 100 μL를 가하여 상온에서 5분 동안 반응시키고 ELISA autoreader를 사용하여 490 nm에서 흡광도를 측정하였다. 이때 양성대조군으로 nordihydroguaiaretic acid(NDGA)을 사용하였으며, 저해율을 계산하였다. 5-LO Inhibitory Activity Measurement: The 5-LO inhibitory activity was measured using a lipoxygenase inhibitor screening assay kit. After 10 μL of the sample, 90 μL of 5-LO (220 units / mL) and 10 μL of 1 mM arachidonic acid were added and reacted at room temperature for 5 minutes. Then, 100 μL of chromogen was added and reacted at room temperature for 5 minutes, followed by ELISA. Absorbance was measured at 490 nm using an autoreader. Nordihydroguaiaretic acid (NDGA) was used as a positive control and inhibition rate was calculated.

COX-2 저해 활성 측정: COX-2 억제 효능은 COX inhibitor screening assay kit를 이용하여 실험하였다. 시료 20 μL에 hemo 10 μL, 효소 5 μL, buffer 950 uL를 넣고 37℃에서 반응 후 10 μL의 아라키돈산을 첨가하여 37℃에서 2분간 반응시켜 COX-2를 활성화시킨 후 이를 50 μL를 취하여 200 μL의 색원체를 넣은 후 25℃에서 90분간 반응시킨 후 ELISA autoreader를 사용하여 420nm에서 흡광도를 측정하였다. 이때 양성대조군으로 비스테로이드성 소염제(NSAIDs) 중의 하나인 indomethacin을 사용하였으며, 저해율을 산출하였다.
Determination of COX-2 Inhibitory Activity: COX-2 inhibitory efficacy was tested using a COX inhibitor screening assay kit. Hemo 10 μL, enzyme 5 μL, buffer 950 uL was added to 20 μL of the sample. After reaction at 37 ° C, 10 μL of arachidonic acid was added and reacted at 37 ° C for 2 minutes to activate COX-2. After adding the color source of μL and reacted for 90 minutes at 25 ℃, the absorbance was measured at 420nm using an ELISA autoreader. At this time, indomethacin, one of nonsteroidal anti-inflammatory drugs (NSAIDs), was used as a positive control, and the inhibition rate was calculated.

실험 결과(도 3), 8가지 생약의 수증기증류액의 5-LO 저해 효능은 25 μg/mL의 농도에서 정향이 86.15%로 가장 컸고 고본(66.48%) 및 당귀(64.27%) 순으로 저해 효능이 컸으며, 정향은 양성대조군인 NDGA 5 μg/mL 농도에서의 활성과 유사하였다. 또한 COX-2 저해 효능은 25 μg/mL의 농도에서 박하가 91.94%로 가장 컸고 정향 및 당귀(89.46%), 노간주(88.70%) 순으로 저해 효능이 컸으며, 정향은 양성대조군인 indomethacin 5 μg/mL 농도에서의 활성과 유사하였다. 따라서 8가지 생약 중 정향이 항염증작용이 가장 높은 것으로 판단할 수 있었다.
As a result of experiment (Fig. 3), the 5-LO inhibitory efficacy of the steam distillates of the eight herbal medicines showed the highest clove with 86.15% of clove at the concentration of 25 μg / mL, followed by the head (66.48%) and Angelica (64.27%). The cloves were similar to the activity at 5 μg / mL of the NDGA positive control. The highest inhibitory effect of COX-2 was at the concentration of 25 μg / mL, the highest at the concentration of 91.94%, and at the concentration of clove, Angelica (89.46%), and juju (88.70%), the clove was 5 μg of indomethacin. Similar to activity at / mL concentration. Therefore, among the eight herbs, clove could be judged to have the highest anti-inflammatory effect.

<실험예2> GC-MS에 의한 정향의 향기성분 분석Experimental Example 2 Analysis of Flavor Components in Cloves by GC-MS

먼저 정향의 향기성분은 SDE 및 SPME를 이용한 2가지 방법으로 추출하였는데 SDE은 앞서 수증기증류액 제조시 추출하였던 방법이며 SPME의 경우 바이알에 정향을 넣고 270℃에서 5분 동안 시료를 가열한 다음 1분 동안 향기를 흡착시키고 기기에 1분 동안 시료를 주입하여 추출하였고, 추출된 정향 향기 성분은 아래의 조건과 같이 GC-MS를 이용하여 분석하였다(표 4).First, the fragrance components of the clove were extracted by two methods using SDE and SPME. SDE was extracted during the steam distillation. In the case of SPME, put the cloves into a vial and heat the sample at 270 ℃ for 5 minutes, and then 1 minute. The fragrance was adsorbed and extracted by injecting a sample into the device for 1 minute, and extracted clove fragrance components were analyzed using GC-MS as shown below (Table 4).

Figure pat00004
Figure pat00004

실험 결과(도 4), 8가지 생약 중 항산화, 항노화 및 항염증 작용이 우수한 정향의 주된 향기 성분은 eugenol로 확인되었으며, 이 성분이 정향의 생리활성에 크게 기여하였을 것으로 사료되었다.
As a result of the experiment (Fig. 4), among the eight herbs, the main flavor component of the clove excellent in antioxidant, anti-aging and anti-inflammatory action was identified as eugenol, which is thought to have contributed greatly to the bioactivity of the clove.

<실험예3> 3가지 eugenol 유도체의 생리활성(in vitro) 비교Experimental Example 3 Comparison of Physiological Activities of Three Eugenol Derivatives

3가지 eugenol 유도체의 항산화 및 항노화 활성의 측정은 <실험예1>과 동일하며, 항염증활성은 Block et al., (1988)의 방법에 따라 측정하였다. 즉 0.1 M Tris-HCl buffer (pH 8.5) 2 mL에 추출물 20 μL와 soybean 15-lipoxygenase (1 nM, final concentration) 20 μL를 넣어 5분간 반응시키고 에탄올에 용해한 linoleic acid(110 μM, final concentration) 50 μL를 기질로 첨가한 후 1분간 반응시키고 234 nm에서 흡광도를 측정하였다. 15-soybean lipoxygenase 저해활성은 DPPH 라디칼 소거활성 계산 방법과 동일하며, 그 값은 IC50치(50%의 저해활성을 나타낸는 농도)로 나타내었다.
Antioxidant and anti-aging activity of the three eugenol derivatives were the same as in <Experimental Example 1>, and the anti-inflammatory activity was measured according to the method of Block et al. (1988). In other words, 20 μL of extract and 20 μL of soybean 15-lipoxygenase (1 nM, final concentration) were added to 2 mL of 0.1 M Tris-HCl buffer (pH 8.5) for 5 minutes and linoleic acid (110 μM, final concentration) dissolved in ethanol. After the addition of μL to the substrate was reacted for 1 minute and the absorbance was measured at 234 nm. The 15-soybean lipoxygenase inhibitory activity was the same as the DPPH radical scavenging activity calculation method, and the value was expressed as IC50 value (concentration showing 50% inhibitory activity).

실험 결과, 정향의 주된 생리활성물질로 확인된 eugenol과 그 유도체인 methyl- eugenol 및 acetyleugenol의 생리활성을 비교한 결과, eugenol은 DPPH 라디칼 소거 활성과 tyrosinase 저해 효능이 methyleugenol 및 acetyleugenol보다 큰 반면, methyleugenol은 soybean 15-lipoxygenase 저해 활성이 eugenol 및 acetyleugenol에 비해 2-5배 정도 큰 것을 알 수 있었다(표 5). As a result, we compared eugenol and its derivatives, methyl-eugenol and acetyleugenol, which were identified as the main bioactive substances in cloves. Soybean 15-lipoxygenase inhibitory activity was 2-5 times greater than eugenol and acetyleugenol (Table 5).

Figure pat00005

Figure pat00005

<실험예4> 세신을 함유한 고품질의 한방증류액의 제조, 향기성분 및 생리활성Experimental Example 4 Preparation of High-Quality Herbal Distillates Containing Sessin, Flavor Components, and Physiological Activities

기존 및 본 발명 신규한 한방증류액의 향기성분 및 함량 비교Comparison of Aroma Components and Contents of Existing and Inventive Novel Herbal Distillates

하늘호수로부터 기존 한방증류액 및 세신이 함유된 새로운 한방증류액의 향기 성분은 GC-MS를 이용하여 분석하였다.The fragrance components of the existing herbal distillate and the new herbal distillate containing sessin from Sky Lake were analyzed using GC-MS.

실험 결과(도 5), 기존 한방증류액 및 수증기증류액의 주된 향기성분은 eugenol이었으며, 세신과 상백피를 첨가한 새로운 한방증류액 및 수증기증류액의 향기성분은 eugenol과 methyleugenol 및 acetyleugenol로 차이가 있다. 기존 한방증류액의 eugenol 함량은 82.66 ppm이었으며, 새로운 한방증류액의 eugenol 함량은 119.17 ppm이고 methyleugenol 및 acetyleugenol의 함량은 6.5 ppm 및 28.74 ppm이었다. 따라서 새로운 한방증류액은 기존의 한방증류액에 비해 eugenol 유도체의 함량이 높았으므로 보다 좋은 생리활성을 가질 것으로 사료된다(도 6).
Experimental results (Fig. 5), the main fragrance component of the existing herbal distillate and steam distillate was eugenol, the fragrance components of the new herbal distillate and steam distillate added sessin and baekryepi differs between eugenol, methyleugenol and acetyleugenol . The eugenol content of the existing herbal distillate was 82.66 ppm, the eugenol content of the new herbal distillate was 119.17 ppm, and the contents of methyleugenol and acetyleugenol were 6.5 ppm and 28.74 ppm, respectively. Therefore, the new herbal distillate has a higher content of eugenol derivatives than the conventional herbal distillate, so it is considered to have better physiological activity (FIG. 6).

기존 및 본 발명 신규한 한방증류액의 향기성분 및 함량 비교Comparison of Aroma Components and Contents of Existing and Inventive Novel Herbal Distillates

항산화활성: 기존의 한방증류액에 세신 및 상백피를 첨가한 신규한 한방증류액의 DPPH 라디칼 소거 활성은 각각 22.02% 및 94.0%로서 본 발명의 신규한 한방증류액이 항산화활성이 우수한 것으로 판단되었다(도 7).
Antioxidant Activity: DPPH radical scavenging activity of the new herbal distillate added with sacin and lettuce was added 22.02% and 94.0%, respectively, and it was determined that the novel herbal distillate of the present invention had excellent antioxidant activity. 7).

본 발명은 기존 한방증류액에 세신 및 상백피를 첨가한 신규한 한방증류액을 제공하는 효과가 있고 항산화, 항노화 및 항염증 기능성 추출액을 제공하는 효과가 있으므로 바이오의료산업상 유용한 발명인 것이다.The present invention is useful in the biomedical industry because it has the effect of providing a novel herbal distillate added sessin and baekryepi to the existing herbal distillate and provides an antioxidant, anti-aging and anti-inflammatory functional extract.

Claims (5)

노간주, 목향, 천궁, 당귀, 정향, 고본, 박하, 애엽, 세신, 상백피를 건조하여 증류수를 가하고 또 다른 수기에 에테르를 넣어 수증기 증류장치를 이용하여 추출한 후 감압농축함을 특징으로 하는 한약재의 수증기 증류추출액 제조방법.
Steam of Chinese herbal medicine characterized in that it is extracted by using steam distillation apparatus after adding distilled water by drying dried jujube, Mokhyang, Cheongung, Dongguk, Clove, Gobon, Mint, Apple Leaf, Sessin and Sangbaekpi. Distillation extract preparation method.
제1항 기재의 한약재 수증기 증류추출액을 유효성분으로 함유하는 항산화 또는 항노화 기능성 조성물.
Antioxidant or anti-aging functional composition containing the herbal steam distillation extract of claim 1 as an active ingredient.
제1항 기재의 한약재 수증기 증류추출액을 유효성분으로 함유하는 항염증 기능성 조성물.
An anti-inflammatory functional composition comprising the herbal distillation extract of claim 1 as an active ingredient.
제1항에 있어서, 상기 수증기 증류추출액은 eugenol 유도체를 유효성분으로 함유하는 것이 특징인 한약재의 수증기 증류추출액.
The method of claim 1, wherein the steam distillation extract is a steam distillation extract of the herbal medicine characterized in that it contains eugenol derivatives as an active ingredient.
제4항에 있어서, 상기 eugenol 유도체는 methyleugenol과 acetyleugenol 중 어느 하나인 것이 특징인 한약재의 수증기 증류추출액.The steam distillation extract of herbal medicine according to claim 4, wherein the eugenol derivative is one of methyleugenol and acetyleugenol.
KR1020100041094A 2010-04-30 2010-04-30 Medical plant extract having anti-oxident and anti-inflammatry activity and method of production thereof KR20110121487A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100041094A KR20110121487A (en) 2010-04-30 2010-04-30 Medical plant extract having anti-oxident and anti-inflammatry activity and method of production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100041094A KR20110121487A (en) 2010-04-30 2010-04-30 Medical plant extract having anti-oxident and anti-inflammatry activity and method of production thereof

Publications (1)

Publication Number Publication Date
KR20110121487A true KR20110121487A (en) 2011-11-07

Family

ID=45392374

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100041094A KR20110121487A (en) 2010-04-30 2010-04-30 Medical plant extract having anti-oxident and anti-inflammatry activity and method of production thereof

Country Status (1)

Country Link
KR (1) KR20110121487A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130070062A (en) * 2011-12-19 2013-06-27 (주)아모레퍼시픽 Cosmetic composition for anti-oxidation or skin whintening containing extract of medicinal herbs mixture
CN104090043A (en) * 2014-07-15 2014-10-08 江苏中烟工业有限责任公司 Method for measuring methyleugenol in cigarette mainstream smoke
KR20160008402A (en) 2014-07-14 2016-01-22 한국과학기술연구원 Method for discriminant analysis and standardization of medicinal effect of So-Cheong-Ryoung-Tang

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130070062A (en) * 2011-12-19 2013-06-27 (주)아모레퍼시픽 Cosmetic composition for anti-oxidation or skin whintening containing extract of medicinal herbs mixture
KR20160008402A (en) 2014-07-14 2016-01-22 한국과학기술연구원 Method for discriminant analysis and standardization of medicinal effect of So-Cheong-Ryoung-Tang
CN104090043A (en) * 2014-07-15 2014-10-08 江苏中烟工业有限责任公司 Method for measuring methyleugenol in cigarette mainstream smoke

Similar Documents

Publication Publication Date Title
Srinivasulu et al. Syringic acid (SA)‒a review of its occurrence, biosynthesis, pharmacological and industrial importance
Ali et al. Production of commercially important secondary metabolites and antioxidant activity in cell suspension cultures of Artemisia absinthium L.
Hu et al. Comparative study of antioxidant activity and antiproliferative effect of hot water and ethanol extracts from the mushroom Inonotus obliquus
Boulekbache-Makhlouf et al. Antioxidant capacity of crude extracts and their solvent fractions of selected Algerian Lamiaceae
Lee et al. Antioxidant, inhibition of α-glucosidase and suppression of nitric oxide production in LPS-induced murine macrophages by different fractions of Actinidia arguta stem
Xu et al. An in vitro study on the dental caries preventing effect of oligomeric procyanidins in sorghum episperm
Zampini et al. Evaluation of genotoxic and antigenotoxic effects of hydroalcoholic extracts of Zuccagnia punctata Cav.
KR20170062563A (en) Method of increasing antioxidant and anti-inflammatory activity of Cassiae semen and the fermented extract having increased activity by that
KR100803998B1 (en) Fermented extract of Citrus Sunkii Hort, Method for processing thereof, and the healthy and funtional foods
Yusuf et al. Antimicrobial and antioxidant properties of mistletoe (Viscum album) growing on cola (Cola nitida) tree in Akure North, Nigeria.
KR20110121487A (en) Medical plant extract having anti-oxident and anti-inflammatry activity and method of production thereof
KR101949430B1 (en) Composition for antiinflammatory and antiaging comprising tetragonia tetragonoides extract
Gao et al. Diverse bioactive components from Ginkgo biloba fruit
KR20150015164A (en) Dichloromethane or hexan fraction of Orostachys japonicus with antioxidant activity and use thereof
KR101944082B1 (en) Cosmetics for anti-aging or whitening of skin with ethanol extract of Crataegi fructus fruit and manufacturing method of producing the same
KR101972309B1 (en) Composition for Treating and Preventing Inflammatory Disease Comprising Culture Fluid Extract or Fraction of Endophytic Fungal Strain Isolated from the Rhizome of Reed Plant as an Active Ingredient
KR102058022B1 (en) Composition for antioxidant and anti-inflammatory comprising fraction of Ledum palustre L. extract as effective component
KR101650410B1 (en) Composition comprising Water Extract from Panax ginseng C. A. Mayer, Acanthopanax koreanum Nakai and Dendropanax morbifera Leveille for skin whitening, Functional food and Korean herb cosmetic manufactured by using them
KR20230039369A (en) Health functional stick jelly using rose and chrysanthemum extracts
KR101531293B1 (en) Cosmetic composition with antioxidant, anti-inflammatory and whitening effect containing Ge-7 mixture
KR101373191B1 (en) Fermented microalgae for antioxidant effect and a functional product composition containing the same
Fatiha et al. Algerian mint species: high performance thin layer chromatography quantitative determination of rosmarinic acid and in vitro inhibitory effects on linoleic acid peroxidation
JP2009007268A (en) Salacia-processed product having improved absorptivity of xanthone and method for producing the same
KR20200057176A (en) Composition for treating hyperuricemia containing microalgae kctc18635p extracts and preparation method of the same
Kang et al. A study of physiological activities for cosmeceutical ingredient from fermented Aroniamelanocarpa extract

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application